Renu Gupta Net Worth & Insider Trades

Renu Gupta - Director, Corbus Pharmaceuticals Holdings, Inc

As of May 26, 2017

What is Renu Gupta's Net Worth?

The current estimated net worth of Corbus Pharmaceuticals Holdings, Inc's Director, Renu Gupta, is estimated to be about $141.47K . Renu Gupta owns about 15,000 units of Corbus Pharmaceuticals Holdings, Inc common stock. In the last 3 years at Corbus Pharmaceuticals Holdings, Inc, Renu Gupta has sold an estimated value of $0 worth.

What is Renu Gupta's Past Insider Trading?

Renu Gupta's largest purchase order was 10,000 units , worth over $18.95K on August 19, 2015. In total, Renu Gupta has made about 5 transactions over 3 years of their time at Corbus Pharmaceuticals Holdings, Inc. Renu Gupta usually trades in May and August, with the busiest year in 2015.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Renu Gupta

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Corbus Pharmaceuticals Holdings, Inc's Past Insider Trades?

Corbus Pharmaceuticals Holdings, Inc's most recent insider trade came on August 12, 2022 by Craig Millian who bought 5,000 units worth $1.27K . In the last 8 years, insiders at Corbus Pharmaceuticals Holdings, Inc have sold an estimated value of $969.17K and bought an estimated value of $3.16M worth of shares. Insider trading is most common in May, with the busiest year in 2015. The most active traders at the company are Sean Moran, Chief Financial Officer,  Yuval Cohen, Chief Executive Officer,  and Barbara White, Chief Medical Officer .

Corbus Pharmaceuticals Holdings, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...